<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01503060</url>
  </required_header>
  <id_info>
    <org_study_id>1000025726</org_study_id>
    <nct_id>NCT01503060</nct_id>
  </id_info>
  <brief_title>Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain</brief_title>
  <official_title>Effectiveness of Parent-Led Interventions in Reducing Infant Hypersensitivity to Pain: A Longitudinal Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to find out the effects of routinely using different types of
      pain-relieving strategies during routine immunization injections performed in infants.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2011</start_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hypersensitivity to pain</measure>
    <time_frame>At 15 month vaccination (Visit 5)</time_frame>
    <description>This will be assessed by comparing the pain scores between each active group and the placebo group at 15 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness of interventions</measure>
    <time_frame>At 2,4,6,12 month vaccinations (Visit 1-4)</time_frame>
    <description>This will be assessed by comparing the pain scores between groups</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">352</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Visit 1-4 (2,4,6,12 month vaccinations): Patients will receive standard care
Visit 5 (15 month vaccination): At the last visit all 4 groups will receive all three active interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visit 1-4 (2,4,6,12 month vaccinations): Parents will be taught about managing pain
Visit 5 (15 month vaccination): At the last visit all 4 groups will receive all three active interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visit 1-4 (2,4,6,12 month vaccinations): Parents will be taught about managing pain and their infant will be given sugar
Visit 5 (15 month vaccination): At the last visit all 4 groups will receive all three active interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visit 1-4 (2,4,6,12 month vaccinations): Parents will be taught about managing pain and their infant will be given sugar water and a topical anesthetic
Visit 5 (15 month vaccination): At the last visit all 4 groups will receive all three active interventions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Educational video - Active</intervention_name>
    <description>The active video will instruct parents in techniques related to optimal infant soothing.</description>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Educational Video - Sham</intervention_name>
    <description>The sham video will provide general information about immunization immunization pain management.</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sucrose Placebo (water)</intervention_name>
    <description>Infants will receive 2mL of liquid on the tongue 2 minutes prior to vaccination</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sucrose</intervention_name>
    <description>Infants will receive 2mL of liquid on the tongue 2 minutes prior to vaccination</description>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Placebo</intervention_name>
    <description>Infants will receive 1 g of cream to one or both injection site(s), as required, for 20-30 minutes prior to vaccination</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>Infants will receive 1 g of cream to one or both injection site(s), as required, for 20-30 minutes prior to vaccination</description>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Healthy infants undergoing vaccination.

        Exclusion Criteria:

          1. preterm birth (&lt;37 weeks gestation)

          2. prior hospitalization/surgery (other than postnatal care),

          3. documented/ suspected sensitivity/allergy to amide anaesthetics/vaccines,

          4. mother plans to breastfeed or to use topical anesthetics or sugar water during
             injection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>15 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anna Taddio, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anna Taddio, PhD</last_name>
    <phone>416-813-6235</phone>
    <email>anna.taddio@sickkids.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Outpatient Clinic</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4V 2S2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Moshe Ipp, MD</last_name>
      <phone>(416) 924-7171</phone>
      <email>moshe.ipp@sickkids.ca</email>
    </contact>
    <investigator>
      <last_name>Moshe Ipp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5V1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Taddio, PhD</last_name>
    </contact>
    <investigator>
      <last_name>Anna Taddio, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moshe Ipp, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2011</study_first_submitted>
  <study_first_submitted_qc>December 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2012</study_first_posted>
  <last_update_submitted>November 9, 2015</last_update_submitted>
  <last_update_submitted_qc>November 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Anna Taddio</investigator_full_name>
    <investigator_title>Adjunct Scientist/Pharmacist</investigator_title>
  </responsible_party>
  <keyword>pediatrics</keyword>
  <keyword>Pain</keyword>
  <keyword>Immunization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypersensitivity</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

